|
|
 |
|
Viewing report
|
|
|
|
Atrial Fibrillation Therapeutics - Pipeline Assessment and Market Forecasts to 2017
GlobalData, Dec 2010, Pages: 42
Atrial Fibrillation Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist, has released a new report, “Atrial Fibrillation Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global atrial fibrillation therapeutics. The report identifies the key trends shaping and driving the global atrial fibrillation therapeutics. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global atrial fibrillation therapeutics. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Our analysis shows that the atrial fibrillation therapeutics market grew at a Compound Annual Growth Rate (CAGR) of 4.5%, from $518m in 2001 to $795m in 2009. The market is predicted to grow at an astounding CAGR of 23.5% from 2009 and reach a total value of $4.2 billion by 2017. A high projected growth rate is chiefly attributed to the potentially strong late-stage pipeline. The availability of new first-in-class therapies with better safety and efficacy profiles is therefore expected to drive the growth of the atrial fibrillation therapeutics market in the next few years.
Scope
The report provides information on the key drivers and challenges in the atrial fibrillation therapeutics market. Its scope includes:
- Annualized global atrial fibrillation therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
- The pipeline assessment shows that the atrial fibrillation pipeline is strong and the developmental pipeline consists of 26 first-in-class molecules, such as Azimilide from Warner Chilcott and Xarelto from Bayer. Some of the molecules in Phase II are Celivarone from Sanofi-Aventis and Tecadenoson from Gilead Life Sciences.
- Analysis of the current and future market competition in the global atrial fibrillation therapeutics market. The key market players operating in this market are Pfizer, Sanofi Aventis, Bayer Healthcare, Berlex Laboratories, Boehringer Ingelheim, Merck & Co, Warner Chilcott, Daiichi Sankyo Co and others
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the atrial fibrillation therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global atrial fibrillation therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global atrial fibrillation therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global atrial fibrillation therapeutics market landscape? – Identify, understand and capitalize.
|
|
|
|
